May 20, 2005 The stock market finished a positive week in a quiet session that ended mixed, with listed stocks sinking and Nasdaq rising. Ending a 4-day winning streak, the Centient Biotech 200 was off a relatively small 4 points, or .11%, closing at 3326.86. The S&P 500 was lower by .15%, while Nasdaq moved up .19%. In company news today, Johnson & Johnson received a not approvable verdict on Risperdal for autism, Depomed won FDA approval for a drug for urinary tract infections, Praecis cuts back operations drastically, Actvis bought privately held generic Amide Pharma for $500 million, Ligand will restate results for the last 3 years, stem cell companies did well, and EpiCept pulled its IPO. More details...
